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Introduction
Neurosurgical procedures, such as resection of meningiomas 
or aneurysm clipping, might involve rapid and massive blood 
loss. The decision to measure the haemoglobin (Hb) level, and 
on the basis of the results obtained, when to transfuse blood, 
is important and crucial. A sample of the patient’s blood may 
be sent to the laboratory which allows Hb to be measured 
using various methods, or the Hb value may be obtained by 
arterial blood gas (ABG) analysis (aHb) in the operating room. 
Until recently, these invasive monitoring methods were the 
only ones available to assess Hb levels at intermittent intervals. 
This required clinicians to make a decision about the timing of 
sampling on the basis of clinical conditions. However, a new 
device, Radical-7® Pulse Co-oximeter (SpHb®), (Masimo, Irvine, 
USA), is now available that not only allows Hb concentrations to 
be monitored continuously, but also non-invasively.1 This device 
displays immediate and ongoing changing Hb levels, and may 
help the clinician to determine when a patient’s Hb needs to 
be measured invasively. In our study, we aimed to compare Hb 
levels obtained using non-invasive techniques (SpHb®), with 
those derived using invasive methods.
Method
This study was conducted after approval from our institutional 
ethics committee (Ref: IEC/NP-250/2011, 2 November 2011). 
American Society Anesthesiologists physical status grade I and 
II adult patients of either sex, undergoing general anaesthesia 
for neurosurgical procedures, were included in the study. 
Patients were excluded if they refused to provide consent 
to participate in the study, or if they had peripheral vascular 
disease, haemoglobinopathy and sickle cell disease. Informed 
written consent was obtained from participants, who then 
underwent a detailed pre-anaesthetic examination. 
Patients fasted for eight hours before the scheduled surgery, 
and received premedication with glycopyrrolate 0.2 mg 
intramuscularly, one hour prior to surgery. Anaesthesia 
was induced with fentanyl 2 mg/kg and propofol 1.5–2 μg/
kg. Tracheal intubation was facilitated with rocuronium 
1 mg/kg. Isofl urane (0.8–1.2 minimum alveolar concentrations) 
in a mixture of O2 and N2O (1:2) was used for the maintenance 
of anaesthesia, together with fentanyl 1 μg/kg, as an 
intermittent bolus to maintain analgesia. Vecuronium 0.15 mg/
kg was used intermittently to provide neuromuscular blockade. 
All of the patients received mannitol 1 g/kg 30 minutes before 
opening the duramater. Intravenous fl uids (crystalloid and/
or colloids) were administered to replace the estimated fl uid 
defi cit. Randomly, at any point of time during the surgery, blood 
samples were collected for Hb estimation from the arterial 
blood gas (ABG) machine (aHb), and laboratory (tHb), using an 
automated Hb analyser. Simultaneously, the Hb reading from 
the SpHb® was recorded. Other values displayed on the monitor, 
such as the perfusion index (PI) and methaemoglobin (metHb), 
were also recorded. PI is a calculated value that is displayed with 
the SpHb® because obtaining SpHb® values with a PI < 1.4 is not 
recommended by the manufacturer. Also, the blood oxygen 
saturation values from the standard used pulse oximeter (SpO2), 
SpHb® (SpO2) and arterial blood gas (SO2) were noted at the 
same point of time.
Data analysis was performed using SPSS® 17. Statistical 
analysis summarised the distribution of observed diff erences 
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using means, medians and ranges. Following the approach 
recommended by Bland and Altman,2 owing to the possibility 
of within-individual correlation between successive 
measurements, standard deviation (SD) was estimated 
using mixed-effect, linear regression models.2 Statistical 
significance was achieved when the p-value was less than 
0.05. The Bland-Altmann plot shows the relationship between 
observed differences (between values obtained from two 
diff erent methods) and the mean of two measures. Horizontal 
lines correspond to the limits of agreement, and each dot 
represents individual values. The limits of agreement between 
the two methods were calculated as the mean ± 2 SD of the 
diff erences between the results obtained. If the diff erences 
are normally distributed, 95% of the diff erences between the 
methods lie between these limits, and the two methods can 
be used interchangeably if these diff erences are not clinically 
important.3  
Results
Thirty patients participated in the study. However, the data for 
only 22 patients was analysed, the PI was less than 1.4 in eight 
patients (values of Hb obtained with a PI of less than 1.4 are 
not recommended by the manufacturer). Our primary outcome 
variables were the SpHb®-tHb and SpHb®-aHb differences. 
Table 1 shows the patient characteristics. Table 2 shows the 
PI, metHb, Hb values (SpHb®, laboratory and ABG) and blood 
oxygen saturation (pulse oximeter, SpHb® and ABG) for 
individual patients. The mean Hb concentration was 11.4 g/dl, 
10.59 g/dl and 10.4 g/dl, using the SpHb®, laboratory and ABG, 
respectively. MetHb values were also measured, which were in 
the range of (1.4–3.3%) , and the PI varied between 1.5 and 9.8. 
Table 3 shows the correlation between the paired samples.
Figure 1 displays the Bland-Altmann plot of the relationship 
between the observed diff erences between aHb and SpHb® 
(ABG-SpHb®) and the mean of the two measures. Limits 
of agreement (horizontal lines) indicate that 21 of the 22 
estimates of SpHb® were within the limits. The limits of 
agreement are defi ned as the mean diff erence ± 2 SD, and the 
calculated lower and upper limits for aHb-SpHb® are between 
−3.7 to +3.6. Figure 2 displays the Bland-Altmann plot of the 
relationship between observed diff erences between tHb and 
SpHb® (laboratory-Radical-7® Pulse Co-oximeter) and the mean 
of the two measures. Limits of agreement (horizontal lines) 
indicate that 21 of the 22 estimates of SpHb® were within the 
limits (−4.7 to +3). Figure 3 displays the Bland-Altmann plot of 
Table 1: Patient characteristics
Weight in kg* 67.3 (10.26)
Age in years* 30.19 (11.63)






Basal ganglia bleed 4
Aneurysm 2
* mean (standard deviation)
Table 2: Data of individual patients obtained from the Radical-7® Pulse Co-oximeter, the laboratory, arterial blood gas and the pulse oximeter
Patient PI MetHb SpHB® (g/dl) thB (g/dl) ahB (g/dl) (%) Sp02 (%) Sp02  SpHB® (%) S02
1 2.8 2.8 10.3 11.2 11.5 100 99 97.9
2 2.1 1.8 11.1 8.1 8.3 100 100 100
3 2.3 3.3 8.7 9.5 10.1 99 97 97.9
4 1.6 2.3 11.8 11.6 12.5 100 100 100
5 1.6 1.5 9.1 9.1 9.5 100 100 100
6 1.7 2 9.4 11.3 12.2 100 100 100
7 3.9 2 11.9 11.3 12.1 100 100 99.9
8 1.5 1.8 13.9 11 12.1 100 100 100
9 4.6 2.3 11.6 10.5 11.7 99 100 100
10 3.9 1.8 9.4 9.2 9.5 99 98 100
11 1.6 1.6 9.8 8.3 8.8 98 100 99.9
12 3.2 2.8 12.1 12.6 12.7 100 100 100
13 8.4 1.5 14 12.7 14.5 99 100 100
14 4.6 2.4 12.5 13 14.8 99 98 100
15 1.6 2.1 12.4 12.6 13.5 98 97 98
16 4.1 2.6 18 11.2 12.7 99 100 100
17 1.4 1.4 11.7 11 12.3 100 100 100
18 5.2 2 14.4 10.4 11.6 100 100 100
19 2.2 2.2 9.3 10.1 10.9 100 100 100
20 2.5 2.1 8.4 7 7.2 99 100 100
21 9.8 1.6 9.4 8.7 9.3 100 100 100
22 8.1 1.6 11.8 12.6 12.5 100 100 100
aHb: haemoglobin estimation (arterial blood gas), MetHb: methaemoglobin, PI: perfusion index, SO2: oxygen saturation (arterial blood gas), SpHb®: 
haemoglobin estimation using the Radical-7® Pulse Co-oximeter, SpO2: oxygen saturation (pulse oximeter), SpO2 SpHb®: oxygen saturation (SpHb®), 
tHb: haemoglobin estimation (laboratory)
Table 3: Paired sample correlation between the various methods of haemoglobin estimation
Pairs n Correlation Significance
Pair 1: Haemoglobin estimation (SpHb®) and haemoglobin estimation (tHb) 22 0.553 0.008
Pair 2: Haemoglobin estimation (SpHb®) and haemoglobin estimation (ABG) 22 0.634 0.002
Pair 3: Haemoglobin estimation (tHb) and haemoglobin estimation (ABG) 22 0.970 0.000
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the relationship between observed diff erences between aHb 
and tHb (ABG-laboratory) and the mean of the two measures. 
Limits of agreement (horizontal lines) indicate that 22 of the 
22 estimates were within the limits (−0.26 to +1.84). In Figures 
4 and 5, the regression lines show the relation between the 
SpHb® and tHb (laboratory) trends and SpHb® and aHb (ABG) 
trends, respectively. 
Discussion
The fi ndings of our study suggest that, although the non-
invasive monitor provided continuous and immediate Hb 
values, currently, it is unable to replace invasive Hb monitoring 
techniques. Based on the results of the Bland–Altman plots, the 
two methods can be used interchangeably if the diff erences 
fall between the 95% confi dence interval (CI) of the diff erence, 
and if the diff erences are not clinically important. In this study, 
the calculated 95% CI for the difference calculated on the 
sample (ABG analysis and SpHb®) was −3.7 to 3.6. Therefore, 
a measurement might really be 10 mg/dl, but could be 
reported to be low as 6.3 mg/dl or as high as 13.6 mg/dl. This 
is undoubtedly a clinically important diff erence, and hence 
making decisions for blood transfusions based on these results 
would not be acceptable. The same is true for the diff erence 
between SpHb® and the laboratory Hb values. This wide 
variation may be either owing to the small sample size of the 
study, or to a variation in the accuracy of the non-invasive 
ABG: arterial blood gas, aHb: haemoglobin estimation by the ABG method, 
SD: standard deviation, SpHb®: Radical-7® Pulse Co-oximeter
Figure 1: Bland–Altmann plot of relationship between observed 
differences between aHb-SpHb® (ABG-Radical-7® Pulse Co-oximeter) 













Average of haemoglobin value from ABG 




























SD: standard deviation, SpHb®: Radical-7® Pulse Co-oximeter, tHb: haemoglobin 
estimation from the laboratory
Figure 2: Bland–Altmann plot of relationship between observed 
differences between tHb-SpHb® (laboratory-Radical-7® Pulse 













Average of haemoglobin value from the laboratory 































ABG: arterial blood gas, aHB (ABG): aHb: haemoglobin estimation by the ABG 
method (arterial blood gas), SD: standard deviation, tHb: haemoglobin estimation 
from the laboratory
Figure 3: Bland–Altmann plot of relationship between observed 
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SpHB®: Radical-7® Pulse Co-oximeter; R2 = 0.3
Figure 4: Relationship between Radical-7® Pulse Co-oximeter (SpHb®) 
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ABG: arterial blood gas, SpHB®: Radical-7® Pulse Co-oximeter; R2 = 0.4014
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monitor. However, the inaccuracy of SpHb® was the most likely 
explanation as the Hb values obtained from ABG analysis 
demonstrated good correlation with the laboratory values in 
same patients.
Moreover, in 8 out of 30 patients enrolled in the study, the 
Hb values were not obtained using the non-invasive monitor, 
a major limitation thereof. This further questions the clinical 
utility of this device. There are several variables that could have 
infl uenced the diff erences found between the non-invasive 
SpHb® and tHb (laboratory) measurements. Peripheral perfusion 
at the site of the measurement of SpHb® might have infl uenced 
the detection of Hb levels. The function of the SpHb® sensor 
depends on adequate blood fl ow to the fi nger, as indirectly 
refl ected by the PI. The PI is a calculated value that is displayed 
together with the SpHb®, because obtaining SpHb® values 
with a PI < 1.4 is not recommended by the manufacturer.1 
When perfusion diminishes, SpHb® underestimates true Hb, 
so it should not be used to determine the need for blood 
transfusions without validation using a direct (invasive) 
measurement method.1 As perfusion improves, the SpHb® 
becomes a more accurate measurement methodology. 
Therefore, the PI is as useful a clinical guide, as is the actual 
SpHb® measurement.1 In our study, we excluded patients who 
had a PI less than 1.4. In this study, we found poor correlation 
(Table 3 and Figures 4 and 5) between the non-invasive (SpHb®) 
and invasive methods (laboratory and ABG). The correlation co-
effi  cient between the SpHb® and laboratory values was 0.553, 
and that between the SpHb® and arterial blood gas analysis 
values was 0.634, as against the laboratory and arterial blood 
gas analysis values, which had good correlation (a correlation 
co-effi  cient of 0.97). The correlation value close to 0.5 showed 
virtually no correlation. Nelson’s syndrome was detected in one 
sample in which Hb determination by SpHb® was fairly high 
(18 g/dl) in comparison to the Hb values from the laboratory 
and ABG method. The SpHb® values in this sample did not lie 
within the limits of correlation. However, the laboratory and 
arterial gas blood analysis values correlated well in this patient. 
This might partly explain the poor correlation between the non-
invasive and invasive techniques.
Hahn et al4 recently published the results of a study using the 
SpHb® (version 7.4.0.9), with a repeated-use probe that lasts for 
60 hours. The authors concluded that non-invasive continuous 
Hb monitoring (SpHb®) could not provide useful kinetic data in 
individuals during volume loading. In addition, two other recent 
works that assessed the same device reported controversial 
results on the accuracy of this device.4,5 Specifi cally, an inverse 
relationship was found between the pulse-oximeter saturation 
(SpO2) value and bias in the SpHb® measurement in one study.6
A recent pilot study assessed the relationship between the 
fraction-of-inspired oxygen (FiO2) and SpHb®, as indicated 
by the SpHb®.7 While patients received 100% oxygen via a 
facemask, FiO2, SpO2  and SpHb® were continuously recorded 
until the end-expiratory oxygen fraction was > 90%. Thereafter, 
anaesthesia was initiated. The mean SpHb® between FiO2  at 
21%, and FiO2  at 100%, increased in four patients, decreased 
in two and remained stable in two, resulting in an overall 
signifi cant increase of SpHb® during pre-oxygenation (non-
linear, mixed-eff ect model). There was no change in volume or 
blood mass.7
Preliminary evidence from studies in non-obstetric surgical 
patients indicates that the mean difference in SpHb® to 
aHb is approximately 1 g/dl.5,8,9 Butwick et al10 reported that 
SpHb® values from the SpHb® were higher than laboratory 
Hb concentrations in 16/17 venous and arterial blood 
samples. Despite a signifi cant correlation between SpHb® and 
laboratory Hb values (r = 0.90), they suspected that this device 
overestimated SpHb® values as median SpHb® values were 
signifi cantly higher than laboratory Hb values. With further 
improvements in technology, we may be able to gain better 
insight into the relationship between perfusion, acute changes 
in Hb and intravascular volume through the performance of this 
non-invasive monitor, and in future, non-invasive Hb monitor 
(SpHb®) may become the standard monitor of care for assessing 
patients at risk of bleeding, and also to guide transfusion 
therapy.1 
On the basis of the fi ndings in this study, we propose that the 
SpHb® does not have suffi  cient accuracy to minimise the need 
for invasive Hb monitoring, and could not be used eff ectively 
in eight out of 30 (27%) patients because of low PI due to poor 
perfusion.
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